Switzerland
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -5.52 B
|
Dec. 31, 2023 | USD 333.72 | 0.27% |
|
Switzerland |
|
2 |
USD -3.81 B
|
Dec. 31, 2024 | USD 104.72 | -0.12% |
|
Switzerland |
|
3 |
USD -1.56 B
|
Dec. 31, 2024 | USD 651.30 | 2.02% |
|
Switzerland |
|
4 |
USD -1.10 B
|
March 31, 2024 | USD 191.54 | -1.41% |
|
Switzerland |
|
5 |
USD -932.38 M
|
Dec. 31, 2023 | USD 186.64 | 0.38% |
|
Switzerland |
|
6 |
USD -851.00 M
|
Dec. 31, 2023 | USD 90.37 | -1.60% |
|
Switzerland |
|
7 |
USD -523.79 M
|
Dec. 31, 2023 | USD 44.82 | -1.37% |
|
Switzerland |
|
8 |
USD -216.50 M
|
March 31, 2024 | USD 382.54 | -3.00% |
|
Switzerland |
|
9 |
USD -142.55 M
|
March 31, 2024 | USD 344.40 | -1.64% |
|
Switzerland |
|
10 |
USD -62.12 M
|
Dec. 31, 2023 | USD 77.27 | -1.62% |
|
Switzerland |
|
11 |
USD -46.99 M
|
Dec. 31, 2023 | USD 551.47 | -0.65% |
|
Switzerland |
|
12 |
USD -32.91 M
|
Dec. 31, 2023 | USD 21.72 | -0.35% |
|
Switzerland |
|
13 |
USD -22.34 M
|
Dec. 31, 2023 | USD 74.55 | -2.22% |
|
Switzerland |
|
14 |
USD -16.26 M
|
Dec. 31, 2023 | USD 84.79 | -0.13% |
|
Switzerland |
|
15 |
USD -11.51 M
|
Dec. 31, 2023 | USD 24.85 | 0.68% |
|
Switzerland |
|
16 |
USD -2.87 M
|
Dec. 31, 2023 | USD 161.30 | -1.97% |
|
Switzerland |
|
17 |
USD -682.95 K
|
Dec. 31, 2023 | USD 5.05 | -4.17% |
|
Switzerland |
|
18 |
USD -57.01 K
|
Dec. 31, 2023 | USD 22.91 | 2.51% |
|
Switzerland |
The Eyewear company in Switzerland with the highest Capital Expenditure is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD -5.52 B.
The Eyewear company in Switzerland with the lowest Capital Expenditure is Oculis Holding AG (NasdaqGM: OCS) at USD -57.01 K.
The top 10 Eyewear companies in Switzerland by Capital Expenditure are Roche Holding AG, Novartis AG, Lonza Group AG, Compagnie Financière Richemont SA, The Swatch Group AG, Alcon Inc., Avolta AG, Ypsomed Holding AG, Sonova Holding AG and DKSH Holding AG.
The bottom 10 Eyewear companies in Switzerland by Capital Expenditure are Oculis Holding AG, Molecular Partners AG, IVF Hartmann Holding AG, CALIDA Holding AG, Orell Füssli AG, Medartis Holding AG, DocMorris AG, Vaudoise Assurances Holding SA, DKSH Holding AG and Sonova Holding AG.